Self-interest versus group-interest in antiviral control

PLoS ONE

Volumn 3, Issue 2, 2008, Pages

  van Boven, Michiel ^a,b,c,d   Klinkenberg, Don ^a   Pen, Ido ^c   Weissing, Franz J ^c   Heesterbeek, Hans ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

ANTIVIRAL SUSCEPTIBILITY; ANTIVIRAL THERAPY; ARTICLE; COMPARATIVE STUDY; CONTROL STRATEGY; DRUG COST; DRUG EFFICACY; HEALTH PROGRAM; HUMAN; INDIVIDUALIZATION; INFECTION CONTROL; INFECTION RISK; INFLUENZA VIRUS A H5N1; MORTALITY; POPULATION DYNAMICS; PROPHYLAXIS; PUBLIC HEALTH; SARS CORONAVIRUS; THEORETICAL MODEL; VIRUS INFECTION; VIRUS TRANSMISSION; COMPUTER SIMULATION; DISEASE TRANSMISSION; EPIDEMIC; INFLUENZA; RISK; STATISTICS;

AVES;

ANTIVIRAL AGENTS; COMPUTER SIMULATION; DISEASE OUTBREAKS; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, THEORETICAL; RISK; STOCHASTIC PROCESSES;

EID: 45349098096     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001558     Document Type: Article

References (22)

1. De Clercq E (2004) Antivirals and antiviral strategies. Nature Reviews Microbiology 2: 704-720.
2. Baggaley RF, Ferguson NM, Garnett GP (2005) The epidemiological impact of antiretroviral we predicted by mathematical models: a review. Emerging Themes in Epidemiology 2: 9.
3. Cinatl J, Michaelis M, Hoever G, Preiser W, Doerr HW (2005) Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Research 66: 81-97.
4. Groneberg DA, et al. (2005) Treatment and vaccines for severe acute respiratory syndrome. Lancet Infectious Diseases 5: 147-155.
5. Hayden FG (2006) Antivirals for influenza: historical perspectives and lessons learned. Antiviral Research 71: 372-378.
6. Ferguson NM, et al. (2005) Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437: 209-214.
7. Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, et al. (2005) Containing pandemic influenza at the source. Science 309: 1083-1087.
8. Wu JT, Riley S, Fraser C, Leung GM (2006) Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Medicine 3: e361.
9. Jefferson T, Demicheli V, Rivetti D, Jones M, Di Pietrantonj C, et al. (2006) Antivirals for influenza in healthy adults: systematic review. Lancet 367: 303-313.
10. Bauch CT, Galvani AP, Earn DJD (2003) Group interest versus self interest in smallpox vaccination policy. Proceedings of the National Academy of Sciences USA 100: 10564-10567.
11. Bauch CT, Earn DJD (2004) Vaccination and the theory of games. Proceedings of the National Academy of Sciences USA 101: 13391-13394.
12. Bauch CT (2005) Imitation dynamics predict vaccinating behavior. Proceedings of the Royal Society London B 272: 1669-1675.
13. Galvani AP, Reluga TC, Chapman GB (2007) Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proceedings of the National Academy of Sciences USA 104: 5692-5697.
14. Reluga TC, Bauch CT, Galvani AP (2006) Evolving public perceptions and stability in vaccine uptake. Mathematical Biosciences 204: 185-198.
15. Diekmann O, Heesterbeek JAP (2000) Mathematical Epidemiology of Infectious Diseases. Chichester: Wiley.
16. Yang Y, Longini IM, Halloran ME (2006) Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups. Applied Statistics 55: 317-330.
17. European Medicines Agency (2006) Scientific discussion of the European Medicines Evaluation Agency (www.emea.europa.eu/humansdocs/PDFs/EPAR/ tamiflu/Tamiflu-H-402-II-20.pdf.
18. Fuyuno I (2007) Tamiflu side effects come under scrutiny. Nature 446: 358-359.
19. Maxwell SRJ (2007) Tamiflu and neuropsychiatric disturbance in adolescents. BMJ 334: 1232-1233.
20. Cojocaru MG, Bauch CT, Johnston MD (2007) Dynamics of vaccination strategies via projected dynamical systems. Bulletin of Mathematical Biology 69: 1453-1476.
21. McCaw JM, McVernon J (2007) Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic. Mathematical Biosciences 209: 336-360.
22. Dushoff J, Plotkin JB, Viboud C, Simonsen L, Miller M, Loeb M, Earn DJ (2007) Vaccinating to protect a vulnerable subpopulation. PLoS Medicine 4: e174.